Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Rocket Pharmaceuticals Inc (NQ: RCKT )

23.32 USD -0.32 (-1.35%)
Streaming Delayed Price Updated: 1:05 PM EST, Dec 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 109,861
Open 23.55
Bid (Size) 23.30 (1)
Ask (Size) 23.43 (1)
Prev. Close 23.64
Today's Range 23.01 - 24.20
52wk Range 23.15 - 67.48
Shares Outstanding 64,442,601
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Rocket Pharmaceuticals Announces Participation in Evercore ISI 4th Annual HEALTHCONx Virtual Conference
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces Gaurav Shah,... 
From Business Wire News Releases
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease
Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces updated data... 
From Business Wire News Releases

Performance

YTD
-58.72%
-58.72%
1 Month
-24.73%
-24.73%
3 Month
-36.25%
-36.25%
6 Month
-44.00%
-44.00%
1 Year
-26.78%
-26.78%

More News

Read More
Rocket Pharmaceuticals to Host Webcast on Nov. 15 at 8:30 a.m. ET to Present Updated Danon Disease Clinical Data
From Business Wire News Releases
Rocket Pharmaceuticals Announces Participation in Stifel 2021 Virtual Healthcare Conference
From Business Wire News Releases
Rocket Pharmaceuticals Announces Danon Disease Presentation at the American Heart Association (AHA) Scientific Sessions 2021
From Business Wire News Releases
Rocket Pharmaceuticals Announces Presentations Highlighting Three Lentiviral Gene Therapies at the 63rd American Society of Hematology (ASH) Annual Meeting
From Business Wire News Releases
Rocket Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Progress
From Business Wire News Releases
Frazier Healthcare Partners Closes Oversubscribed $830 Million Life Sciences Public Fund
From Business Wire News Releases
Frazier Healthcare Partners Announces Several Promotions on Life Sciences Team
From Business Wire News Releases
Rocket Pharma To Test Lower Dose Of Gene Therapy In Genetic Disorder Trial
Tags Market News Health Care RCKT
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Tags BZI/TFM PETV PROG
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.